openPR Logo
Press release

Bone Morphogenetic Protein Market Trends, Growth, Analysis and Forecast - 2025

07-27-2020 01:52 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Bone Morphogenetic Protein Market

Bone Morphogenetic Protein Market

The global bone morphogenetic protein (BMP) market is estimated to grow at a CAGR of nearly 3.0% during the forecast period. Increasing spine injuries are supporting to drive the market growth. Increasing number of road accidents and sports injuries are one of the major causes of spine injuries. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. As of 2019, the estimated number of individuals suffering from spinal cord injury in the US is nearly 291,000. Nearly 78% of new incidences were reported among males.

Get Sample Copy of Bone Morphogenetic Protein (BMP) Market at: https://www.omrglobal.com/request-sample/bone-morphogenetic-protein-bmp-market

The major players operating in the market include Medtronic plc, Merck KGaA, Thermo Fisher Scientific Inc., Johnson & Johnson Services, Inc., and Ember Therapeutics, Inc. In August 2018, Ember Therapeutics, Inc.,

Since 2015-2018/2019, motor vehicle accidents are the major cause of spinal cord injuries (39.3%), which is followed by falls (31.8%), acts of violence (13.5%), sports (8%), medical/surgical (4.3%), and other (3.1%). Nearly 2/3rd of sports injuries were reported from diving. This leads to the increasing demand for spinal fusion procedures in the country. During spine fusion procedure, the surgeon places BMP on a sponge at the surgical site to cause the adjacent bones to fuse together. Traditionally, auto graft was used for bone graft material, which is own hip bone of the patients.

Bone graft material for spinal fusion procedure was harvested from the iliac pelvic bone, which can be a highly painful procedure with longer recovery times and hospitalization times for patients. BMP avoids the requirement for bone grafting procedure, which is very painful, as well as increases the fusion success rate. It can perform better thaniliac graft with a fusion rate of more than 95%. BMP stimulates bone formation and healing of broken bones as it is a naturally occurring protein. It is the only known proteins that are capable of stimulating the formation of new bone.

For More Information, get A full report of Bone Morphogenetic Protein (BMP) Market is available at: https://www.omrglobal.com/industry-reports/bone-morphogenetic-protein-bmp-market

Recombinant human bone morphogenetic protein (rhBMP) has renowned for its significant efficacy to bone grafting. Since 2002, the US FDA cleared BMP product for lumbar spine applications. It was the first genetically engineered product in the US for applications inspine and general orthopedic procedures. INFUSEbone graft is the first commercially available BMP that shown clinically demonstrated osteoconductive. It contains the only BMP approved for spinal fusion. Owing to the safety and efficacy of BMP thaniliac crest autograft (hip) graft harvest, it is being significantly adopted in spine fusion procedures, which in turn, is driving the global BMP market.

Global BMP Market- Segmentation

By Type

Recombinant Human BMP (rhBMP)-2
Recombinant Human BMP (rhBMP)-7

By Application

Trauma
Spinal Fusion
Reconstructive
Oral-Maxillofacial
Others

Global BMP Market– Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa


For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/bone-morphogenetic-protein-bmp-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visithttps://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bone Morphogenetic Protein Market Trends, Growth, Analysis and Forecast - 2025 here

News-ID: 2097253 • Views:

More Releases from Orion Market Research

Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forec …
Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues. To learn more about this report request
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
Global prediabetes market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing product expansion and new drugs in the market. For instance, in January 2024, Novo Nordisk announced the launch of its Wegovy, a GLP-1 analog in the UK. This drug can be prescribed to people with prediabetes and for weight loss purposes.
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global rapid test market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2024-2031). The increasing government initiatives for diagnosing infectious diseases owing to the growing prevalence of infectious diseases and the key developments by the market players. In order to monitor the infection rate of specific pathogens, infection monitoring and surveillance programs have grown over the past few several years. Rapid diagnostic
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Fore …
Global AI in patient engagement market is anticipated to grow at a CAGR of 21.0 % during the forecast period (2024-2031). AI-powered communication tools support patients by addressing their inquiries, scheduling appointments, and providing information about their health conditions and treatments. These tools enhance patient engagement, improve access to healthcare information, and streamline administrative processes for healthcare providers. Furthermore, AI algorithms analyze large datasets, including electronic health records (EHRs), medical

All 5 Releases


More Releases for BMP

Bone Morphogenetic Protein (BMP) Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Bone Morphogenetic Protein (BMP) market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This
Global Bone Morphogenetic Protein (BMP) 2 Sales Market Report 2018
In this report, the global Bone Morphogenetic Protein (BMP) 2 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Free | Request Sample Copy of the Report @ https://bit.ly/2MbknYj Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of
Barcode Saving in BMP, SVG, GIF & TIFF Formats inside Cloud Apps
What's New in this Release? Aspose team is pleased to announce the new release of Aspose.BarCode for Cloud 18.3. This release provides support to save barcode in BMP, SVG, GIF and TIFF format, and released a fully reworked version of .NET, Node.js and PHP Cloud SDKs. There are some important new features included in this release, such as included support for saving barcode in BMP, saving barcode in SVG format
Databar Coded Barcode Generation & Enhanced Barcode Detection from BMP Images us …
What's New in this Release? Aspose team is pleased to announce the new version of Aspose.BarCode for Java 17.9.0. This release includes enhanced DatabarLimited and DatabarExpandedStacked coded barcode generation process. Furthermore overall performance of the API has also been improved in this release. DatabarLimited barcode generation process has been improved. The functionality has been improved in such a way that it now allows only (01) AI and 0 or 1
Bone Morphogenetic Protein (BMP) 2 Market 2017 - Stryker, Medtronic, Cellumed
Apex Research, recently published a detailed market research study focused on the "Bone Morphogenetic Protein (BMP) 2 Market" across the global, regional and country level. The report provides 360° analysis of "Bone Morphogenetic Protein (BMP) 2 Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bone Morphogenetic Protein (BMP) 2 industry, and
bmp media investors: bmp invests in komoot GmbH
Berlin, 7 November 2013 - bmp media investors AG (ISIN DE0003304200) has acquired a 5.34% interest in komoot GmbH in a round of financing. Alongside bmp media investors, other investors include Mittelständische Beteiligungsgesellschaft Berlin-Brandenburg GmbH, Potsdam, and KRW Schindler Investments S.A., Luxembourg. komoot GmbH, based in Potsdam, offers an app of the same name for outdoor activities that allows users to plan and adapt bike rides and hiking expeditions in line